2019 Novel Coronavirus: Pharmacy Resources

Recommendations, clinical resources, and other guidance to help pharmacists navigate the novel coronavirus disease 2019 (COVID-19) pandemic and its implications in community and practice. If you have a subscription including CE, get CE credit for the relevant CE topics.

Note: This is a free resource but requires the creation of a personal account for use.

This tool is intended to assist in COVID-19 pandemic planning efforts in departments of pharmacy and to foster pharmacist involvement in preparedness at the institutional and community levels. This tool is not intended to cover all pandemic planning, but is intended to be useful in identifying gaps and vulnerabilities in a pharmacy department’s readiness for the COVID-19 pandemic

Sample List of Potential Pharmacy Public Health Roles at the Local or State Levels from ASHP

ASHP recommendations for federal policy makers

ASHP recommendations for state policy makers

Centers for Medicare and Medicaid Services Information for Healthcare Facilities Concerning 2019 Novel Coronavirus Illness (2019-nCoV)

CDC has developed two checklists that identify key actions that can be taken now to enhance preparedness for potential or confirmed patients with coronavirus disease 2019 (COVID-19)

A general guide for prescribers, pharmacists, and patients when considering the appropriate use of experimental treatments. These especially include azithromycin, chloroquine, and hydroxychloroquine, but also include baloxavir, lopinavir and ritonavir, oseltamivir, remdesivir, sarilumab, tocilizumab, and sirolimus.